Abstract:Objective To explore the clinical outcome of percutaneous microwave/radiofrequency ablation liver partition and portal vein embolization for planned hepatectomy (PAPEP) for the treatment of hepatocelullar carcinoma (HCC) with insufficient future liver remnant (FLR).Methods The retrospective descriptive research method was taken.The clinical data of 2 patients of giant primary HCC (FLR complicated with cirrhosis) who were admitted to the Zhejiang Province People's Hospital from November 2015 to January 2016 were collected.Treatment plan:ultrasound-guided percutaneous microwave ablation (PMA) or percutaneous radio-frequency ablation (PRA) was performed on patients under intravenous anesthesia,at the same time portal vein embolization (PVE) was conducted.FLR was measured by rescan of computed tomography (CT) at 7-9 days postoperatively,according to FLR hyperplasia and general situation of the patient,right trisegmentectomy and expanded right hemihepatectomy were implemented respectively.Observation indicatiors indicators included (1)standard liver volume (SLV) and FLR before PRA/PVE treatment,(2) liver function,body temperature,FLR and time of FLR hyperplasia after PRA/PVE treatment,(3)liver function,body temperature,complications,FLR and duration of hospital stay after hepatectomy.Follow-up using outpatient examination and telephone interview was performed to detect carcinoma recurrence and other follow-up contents up to March 2016.Results (1) Before PRA + PVE,SLVs of 2 patients were 1 103 mL and 1 132mL,FLRs of 2 patients were respectively 417 mL and 297 mL which occupied the SLV at the percentage of 37.8％ and 26.2％ respectively.(2) After PRA + PVE treatment,there were no changes in liver function and fever.After PRA + PVE treatment,FLR of 2 patients increased to 652 mLand 522 mL,respectively,which occupied the SLV at the percentage of 59.1％ and 46.1％ respectively,with increased rates of 56.4％ and 75.6％ and time of FLR hyperplasia of 10 days and 17 days.The two patients received successful hepatectomy,without intraoperative red blood cell infusion.(3) At postoperative day 3,albumin (Alb),alanine transaminase (ALT),aspartate transaminase (AST) and total bilirubin (TBil) of liver function were 28.0 g/L,63 U/L,39 U/L and 19.0 μmol/L in patient 1 with a temperature of 38 degree,and 24.3 g/L,78 U/L,11 U/L and 38.1 μmol/L in patient 2 with a normal temperature.Liver function of 2 patients was improved after conservative treatment.No severe complications were occurred.Rescan of CT showed the FLR of patients continued increasing.The duration of hospital stay of 2 patients was 10 days and 14 days,respectively.Conclusion PAPEP for HCC with insufficient FLR is safe and effective.

Clinical application of ultrasound guided psychro-circulation percutaneous microwave coagulation therapy (PPMCT) in treatment of unresectable liver cancer (Review of 226 cases)

Clinical Assessment of Sonographically Guided Microwave Coagulation Therapy in Patients with Liver Carcinoma

Clinical application of ultrasound -guided percutaneous microwave coagulation of hepatic tumors adjacent to the gallbladder

[Percutaneous Microwave/Radiofrequency Ablation Liver Partition and Portal Vein Embolization for Planned Hepatectomy for Colorectal Liver Metastases with Insufficient Future Liver Remnant].

Ultrasound guided percutaneous microwave coagulation therapy for liver carcinoma:32 cases clinical analysis

Local therapeutic efficacy of ultrasound-guided percutaneous bipolar radiofrequency ablation for liver cancer

Effect of Percutaneous Microwave Ablation on Liver Cancer and Its Complications in 171 Patients

Percutaneous Microwave Coagulation Therapy for Patients with Primary and Metastatic Hepatic Tumors

Clinical research of percutaneous microwave coagulation therapy with transcatheter arterial chemoembolization and portal vein chemotherapy on advanced liver cancer

[Curative Effect of Percutaneous Microwave Coagulation Therapy for Hepatocellular Carcinoma].

Apply of Psychro-Circulation PMCT in Therapy of Peripheral Lung Cancer

Clinical Assessment of Percutaneous Microwave Ablation for Liver Tumors Abutting Special Locations under B Ultrasound Guidance

Sonography-Guided Percutaneous Microwave Ablation of Intrahepatic Primary Cholangiocarcinoma

Safety Assessment and Therapeutic Efficacy of Percutaneous Microwave Ablation Therapy Combined with Percutaneous Ethanol Injection for Hepatocellular Carcinoma Adjacent to the Gallbladder.

Treatment Of Liver Tumours Adjacent To Hepatic Hilum With Percutaneous Microwave Ablation Combined With Ethanol Injection: A Pilot Study

Ultrasound-guided Percutaneous Microwave Ablation Assisted by Three-Dimensional Visualization Operative Treatment Planning System and Percutaneous Transhepatic Cholangial Drainage with Intraductal Chilled Saline Perfusion for Larger Hepatic Hilum Hepatocellular (D ≥ 3 Cm): Preliminary Results.

Clinical Application of "Water-cooled Shaft-free Microwave Coagulation Instrument" in Percutaneous Microwave Coagulation Therapy of Liver Cancer

Ultrasound-guided percutaneous microwave ablation assisted by three-dimensional planning system combined with transhepatic arterial chemoembolization for treating single large hepatocellular carcinoma: a primary study of survival

Clinical Outcome of Ultrasound-Guided Percutaneous Microwave Ablation on Colorectal Liver Metastases.

Impact of Timing and Cycles of Systemic Chemotherapy on Survival Outcome of Colorectal Liver Metastases Patients Treated by Percutaneous Microwave Ablation

ORIGINAL ARTICLES WITH ENGLISH ABSTRACT Ultrasound Guided Hyperthermal Ablation Therapies for Hepatocelular Carcinoma